2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid

Catalog No.: 
ACDHJP617
CAS No.: 
25947-11-9
Molecular Formula: 
C10H8N2O3
Molecular Weight: 
204.18
2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$111.00In stockIn stock
25g95%$551.00In stockIn stock
100g95%$2060.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid
IUPAC Name2-(4-oxo-3,4-dihydrophthalazin-1-yl)acetic acid
MDL No.MFCD00085017
Molecular FormulaC10H8N2O3
Molecular Weight204.18
SMILESO=C(O)CC1=NNC(C2=C1C=CC=C2)=O
InChI KeyZEDQLIHBPGNGEC-UHFFFAOYSA-N
Synonym25947-11-9 | 2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid | (4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid | 2-(4-oxo-3H-phthalazin-1-yl)acetic acid | 3,4-Dihydro-4-oxo-1-phthalazineacetic acid | 1-PHTHALAZINEACETIC ACID, 3,4-DIHYDRO-4-OXO- | MFCD00085017 | (4-Oxo-3,
CAS No.25947-11-9
PubChem CID348621

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDHJP617 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTDAL617 route compound structure diagram
    ACTDAL61725947-14-2In Stock
  2. Then
  3. ACDHJP617 route product structure diagram
    ACDHJP61725947-11-9In Stock
Inquiry

2. ACDHJP617 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDHJP617 route product structure diagram
    ACDHJP61725947-11-9In Stock
Inquiry

3. ACDHJP617 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDHJP617 route product structure diagram
    ACDHJP61725947-11-9In Stock
Inquiry

Comments (0)